However, another subset of the prostate cancers with low SLFN11 expression had low promoter methylation (Figure 9B), which was previously demonstrated using a diverse panel of cancer cell lines to predict epigenetic regulation of SLFN11 (29). The gene discussed is SLFN11; the disease is cancer.